DrugBiological
Clostridia Strain Formulation VE303 clinical trials
Also written VE303.
Keep track of what changes. Save the Clostridia Strain Formulation VE303 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- VE303
- 4
Studies by the year they started
4 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 1
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Clostridia Strain Formulation VE303 is read from its arms, and is right about nine times in ten.
Testing it · 4
- VE303 for Prevention of Recurrent Clostridioides Difficile InfectionRecruitingPhase 3Vedanta Biosciences, Inc.NCT06237452Written as VE303
- VE303 for Treatment of Hepatic Encephalopathy (HE)CompletedPhase 2Patricia BloomNCT04899115Written as VE303
- Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile InfectionCompletedPhase 2Vedanta Biosciences, Inc.NCT03788434Written as VE303
- First-in-human Study of VE303 in Healthy Adult VolunteersCompletedPhase 1Vedanta Biosciences, Inc.NCT04236778Written as VE303